The Dutch subsidiary of the luxury brand has agreed to pay a settlement of nearly $600,000 in a money laundering and terrorist financing case.
Source link
Prices, pipelines, and patent cliffs: Inside a pharmaceutical company’s big shakeup
This earnings season, Europe’s largest pharmaceutical companies have reported results ranging from 7% better to 3% worse – but no one really cares. Instead, drugmakers are looking ahead, with 2026…





